{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T23:27:49Z","timestamp":1786663669258,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Cancer Institute"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05336-y","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T10:45:40Z","timestamp":1781001940000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic and health system constraints in pediatric hematologic malignancies in East Africa and implications for WHO classification reconsidering in limited resource settings"],"prefix":"10.1007","volume":"17","author":[{"given":"Terry","family":"Vik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Kussick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eda","family":"Holl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Boova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Lotodo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Kigen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler","family":"Severance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6659-2524","authenticated-orcid":false,"given":"LaToya","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"issue":"1","key":"5336_CR1","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12939-023-01962-y","volume":"22","author":"O Omotoso","year":"2023","unstructured":"Omotoso O, Teibo JO, Atiba FA, Oladimeji T, Paimo OK, Ataya FS, Batiha GE, Alexiou A. Addressing cancer care inequities in sub-Saharan Africa: current challenges and proposed solutions. Int J Equity Health. 2023;22(1):189.","journal-title":"Int J Equity Health"},{"key":"5336_CR2","unstructured":"Acquah J et al. Modelling incidence and mortality cancer parameters with respect to GLOBOCAN 2020Age standardized world estimates. Heliyon. 20204."},{"issue":"9","key":"5336_CR3","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1002\/ijc.34163","volume":"151","author":"A Mafra","year":"2022","unstructured":"Mafra A, Laversanne M, Gospodarowicz M, et al. Global patterns of non-Hodgkin lymphoma in 2020. Int J Cancer. 2022;151(9):1474\u201381. . https:\/\/doi.org\/10.1002\/ijc.34163","journal-title":"Int J Cancer"},{"key":"5336_CR4","unstructured":"Washington DC. Disease and Mortality in Sub-Saharan African (ed 2). World Bank; 2006. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK2279\/"},{"key":"5336_CR5","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1001\/jamaoncol.2021.6987","volume":"8","author":"JM Kocarnik","year":"2022","unstructured":"Global Burden of Disease 2019 Cancer Collaboration, Kocarnik JM, Compton K, Dean FE, Fu W, Gaw BL, et al. Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the global burden of disease study 2019. JAMA Oncol. 2022;8:420\u201344. . https:\/\/doi.org\/10.1001\/jamaoncol.2021.6987","journal-title":"JAMA Oncol"},{"key":"5336_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40164-021-00198-2","volume":"10","author":"M Keykhaei","year":"2021","unstructured":"Keykhaei M, Masinaei M, Mohammadi E, Azadnajafabad S, Rezaei N, Saeedi Moghaddam S, et al. A global, regional, and national survey on burden and Quality of Care Index (QCI) of hematologic malignancies; global burden of disease systematic analysis 1990\u20132017. Exp Hematol Oncol. 2021;10:11. . https:\/\/doi.org\/10.1186\/s40164-021-00198-2","journal-title":"Exp Hematol Oncol"},{"issue":"6","key":"5336_CR7","first-page":"3294","volume":"11","author":"P Torres-Perez","year":"2021","unstructured":"Torres-Perez P, \u00c1lvarez-Satta M, Arrazola M, Ega\u00f1a L, Moreno-Valladares M, Villanua J, Ruiz I, Sampron N, Matheu A. Frailty is associated with mortality in brain tumor patients. Am J Cancer Res. 2021;11(6):3294\u2013303.","journal-title":"Am J Cancer Res"},{"issue":"6","key":"5336_CR8","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1093\/annonc\/mdu540","volume":"26","author":"C Handforth","year":"2015","unstructured":"Handforth C, Clegg A, Young C, et al. The prevalence and outcomes of frailty in older cancer patients: a systematic review. Annals Oncol. 2015;26(6):1091\u2013101. . https:\/\/doi.org\/10.1093\/annonc\/mdu540","journal-title":"Annals Oncol"},{"issue":"23","key":"5336_CR9","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1001\/jama.2022.10019","volume":"327","author":"HD Larkin","year":"2022","unstructured":"Larkin HD. Cancer Deaths May Double by 2030 in Sub-Saharan Africa. JAMA. 2022;327(23):2280. . https:\/\/doi.org\/10.1001\/jama.2022.10019","journal-title":"JAMA"},{"key":"5336_CR10","doi-asserted-by":"publisher","first-page":"e124928","DOI":"10.1172\/jci.insight.124928","volume":"3","author":"KA Oetjen","year":"2018","unstructured":"Oetjen KA, Lindblad KE, Goswami M, Gui G, Dagur PK, Lai C, et al. Human bone marrow assessment by single-cell RNA sequencing, mass cytometry, and flow cytometry. JCI Insight. 2018;3:e124928. . https:\/\/doi.org\/10.1172\/jci.insight.124928","journal-title":"JCI Insight"},{"key":"5336_CR11","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/joim.13508","volume":"292","author":"T W\u00e4sterlid","year":"2022","unstructured":"W\u00e4sterlid T, Cavelier L, Haferlach C, Konopleva M, Fr\u00f6hling S, \u00d6stling P, et al. Application of precision medicine in clinical routine in haematology-challenges and opportunities. J Intern Med. 2022;292:243\u201361. . https:\/\/doi.org\/10.1111\/joim.13508","journal-title":"J Intern Med"},{"key":"5336_CR12","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.cll.2022.04.005","volume":"42","author":"CB Hergott","year":"2022","unstructured":"Hergott CB, Kim AS. Molecular diagnostic testing for hematopoietic neoplasms: linking pathogenic drivers to personalized diagnosis. Clin Lab Med. 2022;42:325\u201347. . https:\/\/doi.org\/10.1016\/j.cll.2022.04.005","journal-title":"Clin Lab Med"},{"issue":"1","key":"5336_CR13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/his.15340","volume":"86","author":"Y Fedoriw","year":"2025","unstructured":"Fedoriw Y, Silva O, Znaor A, Macintyre E. Global view of haematolymphoid tumor classifications and their application in low- and middle-income countries. Histopathology. 2025;86(1):6\u201316.","journal-title":"Histopathology"},{"issue":"11","key":"5336_CR14","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1182\/blood.2022015850","volume":"140","author":"DA Arber","year":"2022","unstructured":"Arber DA, Orazi A, Hasserjian RP, et al. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022;140(11):1200\u201328. . https:\/\/doi.org\/10.1182\/blood.2022015850","journal-title":"Blood"},{"issue":"11","key":"5336_CR15","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1182\/blood.2022015851","volume":"140","author":"E Campo","year":"2022","unstructured":"Campo E, Jaffe ES, Cook JR, et al. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee. Blood. 2022;140(11):1229\u201353. . https:\/\/doi.org\/10.1182\/blood.2022015851","journal-title":"Blood"},{"issue":"10","key":"5336_CR16","doi-asserted-by":"publisher","first-page":"e29768","DOI":"10.1002\/pbc.29768","volume":"69","author":"TS Severance","year":"2022","unstructured":"Severance TS, Njuguna F, Olbara G, et al. An evaluation of the disparities affecting the underdiagnosis of pediatric cancer in Western Kenya. Pediatr Blood Cancer. 2022;69(10):e29768. . https:\/\/doi.org\/10.1002\/pbc.29768","journal-title":"Pediatr Blood Cancer"},{"key":"5336_CR17","doi-asserted-by":"publisher","first-page":"e59776","DOI":"10.2196\/59776","volume":"9","author":"T Severance","year":"2025","unstructured":"Severance T, Olbara G, Njuguna F, Kipng\u2019etich M, Lang\u2019at S, Kugo M, Lemmen J, Treff M, Loehrer P, Vik T. Piloting the Extension for Community Healthcare Outcomes (ECHO) Pediatric Oncology Telehealth Education Program in Western Kenya: Implementation Study. JMIR Form Res. 2025;9:e59776.","journal-title":"JMIR Form Res"},{"issue":"7","key":"5336_CR18","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1136\/archdischild-2013-305052","volume":"99","author":"F Njuguna","year":"2014","unstructured":"Njuguna F, Mostert S, Slot A, et al. Abandonment of childhood cancer treatment in Western Kenya. Arch Dis Child. 2014;99(7):609\u201314. . https:\/\/doi.org\/10.1136\/archdischild-2013-305052","journal-title":"Arch Dis Child"},{"key":"5336_CR19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.blre.2018.07.003","volume":"33","author":"M Damlaj","year":"2019","unstructured":"Damlaj M, El Fakih R, Hashmi SK. Evolution of survivorship in lymphoma, myeloma and leukemia: Metamorphosis of the field into long term follow-up care. Blood Rev. 2019;33:63\u201373. . https:\/\/doi.org\/10.1016\/j.blre.2018.07.003","journal-title":"Blood Rev"},{"issue":"2","key":"5336_CR20","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3390\/vaccines13020114","volume":"13","author":"FAS Mathias","year":"2025","unstructured":"Mathias FAS, Carvalho MGR, Ruiz JC. Therapeutic Vaccines for Hematological Cancers: A Scoping Review of This Immunotherapeutic Approach as Alternative to the Treatment of These Malignancies. Vaccines (Basel). 2025;13(2):114.","journal-title":"Vaccines (Basel)"},{"issue":"7","key":"5336_CR21","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1038\/s41375-022-01625-x","volume":"36","author":"IA Cree","year":"2022","unstructured":"Cree IA. The WHO Classification of Haematolymphoid Tumours. Leukemia. 2022;36(7):1701\u20132.","journal-title":"Leukemia"},{"key":"5336_CR22","unstructured":"WHO, WHO. Classification of Tumours Editorial Board. Haematolymphoid tumours. WHO Classif tumours Ser 2022."},{"issue":"4","key":"5336_CR23","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/joim.13697","volume":"294","author":"R Rosenquist","year":"2023","unstructured":"Rosenquist R, Bernard E, Erkers T, Scott DW, Itzykson R, Rousselot P, Soulier J, Hutchings M, \u00d6stling P, Cavelier L, Fioretos T, Smedby KE. Novel precision medicine approaches and treatment strategies in hematological malignancies. J Intern Med. 2023;294(4):413\u201336.","journal-title":"J Intern Med"},{"issue":"4","key":"5336_CR24","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00428-018-2484-0","volume":"474","author":"MW Rohaan","year":"2019","unstructured":"Rohaan MW, Wilgenhof S, Haanen JBAG. Adoptive cellular therapies: the current landscape. Virchows Arch. 2019;474(4):449\u201361.","journal-title":"Virchows Arch"},{"issue":"1","key":"5336_CR25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13045-023-01492-8","volume":"16","author":"P Zhang","year":"2023","unstructured":"Zhang P, Zhang G, Wan X. Challenges and new technologies in adoptive cell therapy. J Hematol Oncol. 2023;16(1):97. . https:\/\/doi.org\/10.1186\/s13045-023-01492-8","journal-title":"J Hematol Oncol"},{"key":"5336_CR26","doi-asserted-by":"publisher","first-page":"105266","DOI":"10.1016\/j.ebiom.2024.105266","volume":"106","author":"TA Bui","year":"2024","unstructured":"Bui TA, Mei H, Sang R, Ortega DG, Deng W. Advancements and challenges in developing in vivo CAR T cell therapies for cancer treatment. EBioMedicine. 2024;106:105266.","journal-title":"EBioMedicine"},{"key":"5336_CR27","doi-asserted-by":"crossref","unstructured":"Xiao J, Zhang T, Gao F et al. Natural Killer Cells: A Promising Kit in the Adoptive Cell Therapy Toolbox. Cancers (Basel). 2022;14(22):5657.","DOI":"10.3390\/cancers14225657"},{"issue":"1","key":"5336_CR28","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41392-023-01674-3","volume":"8","author":"T Fan","year":"2023","unstructured":"Fan T, Zhang M, Yang J, Zhu Z, Cao W, Dong C. Therapeutic cancer vaccines: advancements, challenges, and prospects. Signal Transduct Target Ther. 2023;8(1):450.","journal-title":"Signal Transduct Target Ther"},{"key":"5336_CR29","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.3332\/ecancer.2021.1296","volume":"15","author":"S Karim","year":"2021","unstructured":"Karim S, Sunderji Z, Jalink M, Mohamed S, Mallick I, Msadabwe-Chikuni SC, Delgarno NJ, Hammad N, Berry S. Oncology training and education initiatives in low and middle income countries: a scoping review. Ecancermedicalscience. 2021;15:1296.","journal-title":"Ecancermedicalscience"},{"issue":"1","key":"5336_CR30","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1200\/JCO.2015.63.0152","volume":"34","author":"FC Asirwa","year":"2016","unstructured":"Asirwa FC, Greist A, Busakhala N, et al. Medical education and training: building in-country capacity at all levels. J Clin Oncol. 2016;34(1):36\u201342. . https:\/\/doi.org\/10.1200\/JCO.2015.63.0152","journal-title":"J Clin Oncol"},{"key":"5336_CR31","doi-asserted-by":"crossref","unstructured":"Ohene-Botwe B, Amedu C, Antwi WK, Abdul-Razak W, Kyei KA, Arkoh S, Mudadi LS, Mushosho EY, Bwanga O, Chinene B, Nyawani P, Mutandiro LC, Piersson AD. Promoting sustainability activities in clinical radiography practice and education in resource-limited countries: A discussion paper. Radiography (Lond). 2024;30 Suppl 1:56\u201361. 10.1016\/j.radi.2024.06.007.","DOI":"10.1016\/j.radi.2024.06.007"},{"issue":"Suppl 1Suppl 1","key":"5336_CR32","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1038\/embor.2008.42","volume":"9","author":"CD Thomas","year":"2008","unstructured":"Thomas CD, Ohlem\u00fcller R, Anderson B, et al. Exporting the ecological effects of climate change. Developed and developing countries will suffer the consequences of climate change, but differ in both their responsibility and how badly it will affect their ecosystems. EMBO Rep. 2008;9(Suppl 1Suppl 1):S28\u201333.","journal-title":"EMBO Rep"},{"issue":"4","key":"5336_CR33","doi-asserted-by":"publisher","first-page":"e257733","DOI":"10.1001\/jamanetworkopen.2025.7733","volume":"8","author":"L Eldridge","year":"2025","unstructured":"Eldridge L, Goodman NR, Chtourou A, Galassi A, Monge C, Cira MK, Pearlman PC, Loehrer PJ, Sr, Gopal S, Ginsburg O. Barriers and Opportunities for Cancer Clinical Trials in Low- and Middle-Income Countries. JAMA Netw Open. 2025;8(4):e257733.","journal-title":"JAMA Netw Open"},{"key":"5336_CR34","doi-asserted-by":"publisher","unstructured":"Chukwu OA, Adibe M. Quality assessment of cold chain storage facilities for regulatory and quality management compliance in a developing country context. Int J Health Plann Manage. 2022;37(2):930\u2013943. https:\/\/doi.org\/10.1002\/hpm.3385","DOI":"10.1002\/hpm.3385"},{"key":"5336_CR35","doi-asserted-by":"publisher","first-page":"116882","DOI":"10.1016\/j.socscimed.2024.116882","volume":"349","author":"A Mengesha","year":"2024","unstructured":"Mengesha A, Bastiaens H, Ravinetto R, Gibson L, Dingwall R. Substandard and falsified medicines in African pharmaceutical markets: A case study from Ethiopia. Soc Sci Med. 2024;349:116882.","journal-title":"Soc Sci Med"},{"key":"5336_CR36","doi-asserted-by":"publisher","first-page":"1467229","DOI":"10.3389\/fmed.2024.1467229","volume":"11","author":"AK Broojerdi","year":"2024","unstructured":"Broojerdi AK, Salvati AL, Abdelfattah MR, Dehaghi ROA, Sillo HB, Gaspar. WHO-listed authorities (WLA) framework: transparent evidence-based approach for promoting regulatory reliance towards increased access to quality-assured medical products. Front Med. 2024;11:1467229.","journal-title":"Front Med"},{"issue":"1","key":"5336_CR37","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1200\/OP.24.00339","volume":"21","author":"SG Raptis","year":"2025","unstructured":"Raptis SG, Shkabari B, Banday S, Gyawali B. Defining and Measuring Financial Toxicity in Low- and Middle-Income Countries. JCO Oncol Pract. 2025;21(1):57\u201368.","journal-title":"JCO Oncol Pract"},{"key":"5336_CR38","doi-asserted-by":"publisher","first-page":"1266533","DOI":"10.3389\/fpubh.2023.1266533","volume":"11","author":"M Azzani","year":"2024","unstructured":"Azzani M, Atroosh WM, Anbazhagan D, Kumarasamy V, Abdalla MMI. Describing financial toxicity among cancer patients in different income countries: a systematic review and meta-analysis. Front Public Health. 2024;11:1266533.","journal-title":"Front Public Health"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05336-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05336-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05336-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T22:51:51Z","timestamp":1786661511000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05336-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5336"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05336-y","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]},"assertion":[{"value":"31 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1174"}}